1. Home
  2. SBSI vs ESPR Comparison

SBSI vs ESPR Comparison

Compare SBSI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southside Bancshares Inc.

SBSI

Southside Bancshares Inc.

HOLD

Current Price

$32.22

Market Cap

920.2M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.09

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSI
ESPR
Founded
1960
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
920.2M
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SBSI
ESPR
Price
$32.22
$3.09
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$33.50
$6.67
AVG Volume (30 Days)
109.7K
5.6M
Earning Date
01-29-2026
03-03-2026
Dividend Yield
4.46%
N/A
EPS Growth
N/A
N/A
EPS
2.30
N/A
Revenue
$236,346,000.00
$303,802,000.00
Revenue This Year
$11.41
$26.11
Revenue Next Year
$5.33
N/A
P/E Ratio
$14.03
N/A
Revenue Growth
N/A
2.83
52 Week Low
$25.85
$0.69
52 Week High
$33.14
$4.18

Technical Indicators

Market Signals
Indicator
SBSI
ESPR
Relative Strength Index (RSI) 62.98 32.93
Support Level $31.11 $3.00
Resistance Level $32.67 $4.18
Average True Range (ATR) 0.62 0.23
MACD 0.06 -0.11
Stochastic Oscillator 83.14 4.26

Price Performance

Historical Comparison
SBSI
ESPR

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: